WallStreetZenWallStreetZen

NASDAQ: GENB
Generate Biomedicines Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Generate Biomedicines revenue was N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $7.2M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GENB annual revenue was $31.9M, with 55.9% growth year-over-year.

GENB revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when GENB announces revenue.

GENB Revenue History By Year

GENB Yearly RevenueGENB RevenueGENB ChangeGENB Revenue Growth
2025-12-31$31.89M$11.43M+55.89%
2024-12-31$20.46MN/AN/A

1 of 1

Generate Biomedicines Revenue FAQ

What was GENB's revenue last quarter?

Generate Biomedicines (NASDAQ: GENB) reported Q1 2026 revenue of $7.22 million up 18.08% year over year. In the same quarter last year, Generate Biomedicines's revenue was $8.82 million.

What was Generate Biomedicines's revenue in 2025?

Generate Biomedicines's annual revenue for the twelve months ending Dec 31, 2025 was $31.89 million, a 55.89% increase year over year.

How much does Generate Biomedicines make in a day?

Based on Generate Biomedicines annual revenue for the past one years, GENB makes an average of $87,378.08 per day.

What was Generate Biomedicines's annual revenue growth in the past year?

As of Q2 2026, Generate Biomedicines's revenue has grown null year over year. Generate Biomedicines's revenue in the past year totaled N/A.

How much does Generate Biomedicines make in a year?

Generate Biomedicines's revenue by year for the past one years is:
  • Generate Biomedicines's revenue for the twelve months ending Dec 31, 2025 was $31.89 million, a 55.89% increase year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.